Trade Summary

1 week ago, Senner Christopher J., serving as EVP, CFO at Exelixis, Inc. (EXEL), sold 64,895 shares at $43.32 per share, for a total transaction value of $2,810,998.00. Following this transaction, Senner Christopher J. now holds 978,815 shares of EXEL.

This sale represents a 6.00% decrease in Senner Christopher J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Exelixis, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.